Annual Total Assets
$376.65 M
-$85.62 M-18.52%
September 30, 2024
Summary
- As of February 7, 2025, ENTA annual total assets is $376.65 million, with the most recent change of -$85.62 million (-18.52%) on September 30, 2024.
- During the last 3 years, ENTA annual total assets has fallen by -$62.14 million (-14.16%).
- ENTA annual total assets is now -23.11% below its all-time high of $489.83 million, reached on September 30, 2019.
Performance
ENTA Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Assets
$376.65 M
-$22.17 M-5.56%
September 30, 2024
Summary
- As of February 7, 2025, ENTA quarterly total assets is $376.65 million, with the most recent change of -$22.17 million (-5.56%) on September 30, 2024.
- Over the past year, ENTA quarterly total assets has dropped by -$85.62 million (-18.52%).
- ENTA quarterly total assets is now -26.65% below its all-time high of $513.50 million, reached on March 31, 2020.
Performance
ENTA Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Assets Formula
Total Assets = Current Assets + Non-Current Assets
ENTA Total Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -18.5% | -18.5% |
| 3 y3 years | -14.2% | -14.2% |
| 5 y5 years | -23.1% | -14.2% |
ENTA Total Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -18.5% | +0.3% | -23.9% | +15.4% |
| 5 y | 5-year | -23.1% | +0.3% | -26.6% | +15.4% |
| alltime | all time | -23.1% | +1343.3% | -26.6% | +1343.3% |
Enanta Pharmaceuticals Total Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | $376.65 M(-18.5%) | $376.65 M(-5.6%) |
| Jun 2024 | - | $398.82 M(-3.6%) |
| Mar 2024 | - | $413.56 M(-3.5%) |
| Dec 2023 | - | $428.50 M(-7.3%) |
| Sep 2023 | $462.27 M(+23.1%) | $462.27 M(-6.6%) |
| Jun 2023 | - | $495.17 M(+51.7%) |
| Mar 2023 | - | $326.44 M(-6.1%) |
| Dec 2022 | - | $347.53 M(-7.4%) |
| Sep 2022 | $375.41 M(-14.4%) | $375.41 M(-2.5%) |
| Jun 2022 | - | $385.21 M(-5.3%) |
| Mar 2022 | - | $406.82 M(-7.7%) |
| Dec 2021 | - | $440.59 M(+0.4%) |
| Sep 2021 | $438.79 M(-9.7%) | $438.79 M(-2.6%) |
| Jun 2021 | - | $450.44 M(-3.7%) |
| Mar 2021 | - | $467.77 M(-2.8%) |
| Dec 2020 | - | $481.01 M(-1.1%) |
| Sep 2020 | $486.13 M(-0.8%) | $486.13 M(-5.0%) |
| Jun 2020 | - | $511.70 M(-0.3%) |
| Mar 2020 | - | $513.50 M(+0.5%) |
| Dec 2019 | - | $510.97 M(+4.3%) |
| Sep 2019 | $489.83 M(+18.3%) | $489.83 M(+3.5%) |
| Jun 2019 | - | $473.48 M(+2.6%) |
| Mar 2019 | - | $461.58 M(+1.6%) |
| Dec 2018 | - | $454.22 M(+9.7%) |
| Sep 2018 | $414.23 M | $414.23 M(+9.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2018 | - | $379.08 M(+6.9%) |
| Mar 2018 | - | $354.65 M(+4.1%) |
| Dec 2017 | - | $340.72 M(+4.3%) |
| Sep 2017 | $326.64 M(+16.1%) | $326.64 M(+18.4%) |
| Jun 2017 | - | $275.84 M(-1.1%) |
| Mar 2017 | - | $278.96 M(+0.2%) |
| Dec 2016 | - | $278.38 M(-1.0%) |
| Sep 2016 | $281.28 M(+14.3%) | $281.28 M(-0.2%) |
| Jun 2016 | - | $281.93 M(+0.1%) |
| Mar 2016 | - | $281.60 M(+1.2%) |
| Dec 2015 | - | $278.38 M(+13.2%) |
| Sep 2015 | $246.01 M(+58.3%) | $246.01 M(+3.5%) |
| Jun 2015 | - | $237.77 M(-3.3%) |
| Mar 2015 | - | $245.88 M(+14.1%) |
| Dec 2014 | - | $215.43 M(+38.6%) |
| Sep 2014 | $155.41 M(+32.9%) | $155.41 M(-2.6%) |
| Jun 2014 | - | $159.51 M(+47.2%) |
| Mar 2014 | - | $108.35 M(-1.6%) |
| Dec 2013 | - | $110.16 M(-5.8%) |
| Sep 2013 | $116.97 M(+124.2%) | $116.97 M(-2.3%) |
| Jun 2013 | - | $119.67 M(-4.7%) |
| Mar 2013 | - | $125.63 M(+73.3%) |
| Dec 2012 | - | $72.48 M(+39.0%) |
| Sep 2012 | $52.16 M(+99.9%) | $52.16 M(-4.0%) |
| Jun 2012 | - | $54.33 M(+108.2%) |
| Sep 2011 | $26.10 M | $26.10 M |
FAQ
- What is Enanta Pharmaceuticals annual total assets?
- What is the all time high annual total assets for Enanta Pharmaceuticals?
- What is Enanta Pharmaceuticals annual total assets year-on-year change?
- What is Enanta Pharmaceuticals quarterly total assets?
- What is the all time high quarterly total assets for Enanta Pharmaceuticals?
- What is Enanta Pharmaceuticals quarterly total assets year-on-year change?
What is Enanta Pharmaceuticals annual total assets?
The current annual total assets of ENTA is $376.65 M
What is the all time high annual total assets for Enanta Pharmaceuticals?
Enanta Pharmaceuticals all-time high annual total assets is $489.83 M
What is Enanta Pharmaceuticals annual total assets year-on-year change?
Over the past year, ENTA annual total assets has changed by -$85.62 M (-18.52%)
What is Enanta Pharmaceuticals quarterly total assets?
The current quarterly total assets of ENTA is $376.65 M
What is the all time high quarterly total assets for Enanta Pharmaceuticals?
Enanta Pharmaceuticals all-time high quarterly total assets is $513.50 M
What is Enanta Pharmaceuticals quarterly total assets year-on-year change?
Over the past year, ENTA quarterly total assets has changed by -$85.62 M (-18.52%)